Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine

NCT02304432 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

2

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia
Bipolar Disorder

Interventions

DRUG: D-cycloserine
DRUG: DCS or placebo
DRUG: D-cycloserine

Sponsor

Mclean Hospital

Collaborators

[object Object]